Mid-Year Report

KEANEY CONSULTING INC. for NOVARTIS VACCINES AND DIAGNOSTICS INC

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Prescription Drug User Fees, Drug Safety Issues, Pediatric Drug Issues, Drug Compounding, Direct-to-Consumer Advertising Issues Drug Regulations, Clinical Trials Issues, Vaccine Issues, Pediatric market Exclusivity Issues, Follow-on Biologics Issues, Brazilian Drug Reference Pricing Issue

LobbyistCovered position, as disclosed
DAVID - KEANEY N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.